MBOAT2 and prostate carcinoma: MBOAT2 exhibited specific upregulation in prostate cancer and its expression was positively correlated with androgen receptor (AR) mRNA expression in prostate cancer, suggesting that MBOAT2 may be a target of AR in prostate cancer cells.